Biotech company Biogen lowered its full-year profit forecast, citing higher costs related to its purchase of drug maker Reata Pharmaceuticals as well as the launch of its Alzheimer's drug.
Share:
More In Business
Cheddar Quick Hit GSTV of January 25th
Cheddar Quick Hit GSTV
3M Cutting About 2,500 Manufacturing Jobs Globally
3M, maker of Post-it notes, industrial coatings and ceramics, is cutting about 2,500 manufacturing jobs worldwide as it looks to align itself with adjusted production volumes.
Morning Alexa Flash Briefings of January 24th
Alexa Flash Briefings
Cheddar Morning News Briefings of January 24th
Cheddar Morning News Briefings
Automakers Drive Toward Customization in Electric Car Overhaul
Getty Images stock photo.
Tax Season Kicks Off
Tax season is here and the IRS will begin accepting and processing returns Monday.
New York’s Second Cannabis Dispensary Claims a Lot of Firsts
When cannabis retail store Smacked Village opens its doors to the public Tuesday morning, it will be the Empire State’s second, licensed, adult-use cannabis retail store. But it also claims a lot of firsts.
M&Ms Says It's Pulling Its Beloved 'Spokescandies'
Candy-maker Mars said it's replacing M&M's beloved spokescandies after criticism over their rebranded looks.
Merriam-Webster Buys Wordle-Style Hit Game, Quordle
Merriam-Webster bought Quordle, a game similar to the hit Wordle.
